Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a dedicated Locations section listing California and Massachusetts sites for the study. The page now includes a revision note (Revision: v3.3.3) and the separate 'California Locations' and 'Massachusetts Locations' entries were removed.SummaryDifference0.3%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. This is a minor page metadata update and does not affect study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study page no longer displays the banner about government funding and NIH operating status, including the guidance to check cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

- Check68 days agoChange DetectedThe updated page shows only minor layout and wording adjustments without altering core study details, eligibility criteria, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check97 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%

- Check104 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.